Global Head, Patient-Driven Outcomes Solutions
Scorpion Therapeutics, Convent Station, New Jersey, us, 07961
Role Summary
Global Head, Patient-Driven Outcomes Solutions (PDOS) leads a global team to deeply integrate patient priorities into evidence generation for clinical programs, delivering differentiated value to internal and external stakeholders. Collaborates cross-functionally to drive innovation in clinical outcomes capabilities using digital health, AI, and real-world data to transform evidence generation, regulatory strategy, and value assessment. Location: Cambridge, MA, Morristown, NJ.
Responsibilities
Strategic Leadership: Manage and direct the head of Clinical Outcomes Assessment Scientists and the digital biomarker and ePRO teams; define and lead Sanofi’s global strategy for patient-driven outcomes across therapeutic areas to deliver best-in-class products with recognized value by patients, clinicians, regulators, and payers; position PDOS within the patient disease strategy to link early evidence generation to labeling, regulatory, and payer decisions; advise R&D leadership on integrating patient perspectives into clinical development evidence generation; build and lead high-performing teams in PROs, digital health, AI, and patient engagement; foster collaboration, inclusion, and continuous learning.
Digital, RWE, AI & Data-Based Medicine: Establish a best-in-class COA roadmap using digital capabilities to differentiate and increase pipeline value; lead next-generation capabilities in digital health technologies, AI/ML modeling and simulation for endpoints, patient stratification, and real-world evidence solutions; drive COA-related RWE strategy to differentiate assets, de-risk trials, and support value demonstration; advance conceptual modeling and dossier authoring using digital capabilities.
Clinical Development, Regulatory and Payer Excellence: Develop and implement next-generation capabilities to advance COA value and evidence generation; embed patient-driven outcomes strategies in trial design aligned with regulatory and HTA expectations; integrate digital COA solutions into trials for ease of implementation and participant experience; develop evidence packages including COAs, digital endpoints, and RWE for regulatory and payer submissions; collaborate with Regulatory Affairs to engage authorities on qualification of digital measures; collaborate with Market Access to link outcomes to value assessments across key markets.
External Engagement: Represent Sanofi in global consortia, regulatory workshops, and scientific forums focused on digital health and patient-centered outcomes; build strategic partnerships with technology providers, academic institutions, and patient advocacy organizations; drive thought leadership in patient-driven outcomes and evolve integrated patient engagement across the company.
Qualifications
Education: Advanced degree in health economics, qualitative and quantitative COA research, or related field.
Experience: 15+ years in the pharmaceutical, biotech, or healthcare industry; 10+ years in a senior leadership role focused on patient-driven outcomes, digital health, and real-world evidence integration; significant experience in digital innovation related to COA and successful value-creating initiatives; proven track record of submissions incorporating patient-centered outcomes; recognized thought leadership in the domain.
Skills: Deep understanding of clinical development, regulatory science, clinical outcomes, and health economics; expertise in digital health technologies and AI/ML applications; strong leadership, communication, and cross-functional collaboration; experience in a global, matrixed environment.
Education
Advanced degree in a relevant discipline related to health economics, qualitative and quantitative COA research.
Additional Requirements
N/A
#J-18808-Ljbffr
Responsibilities
Strategic Leadership: Manage and direct the head of Clinical Outcomes Assessment Scientists and the digital biomarker and ePRO teams; define and lead Sanofi’s global strategy for patient-driven outcomes across therapeutic areas to deliver best-in-class products with recognized value by patients, clinicians, regulators, and payers; position PDOS within the patient disease strategy to link early evidence generation to labeling, regulatory, and payer decisions; advise R&D leadership on integrating patient perspectives into clinical development evidence generation; build and lead high-performing teams in PROs, digital health, AI, and patient engagement; foster collaboration, inclusion, and continuous learning.
Digital, RWE, AI & Data-Based Medicine: Establish a best-in-class COA roadmap using digital capabilities to differentiate and increase pipeline value; lead next-generation capabilities in digital health technologies, AI/ML modeling and simulation for endpoints, patient stratification, and real-world evidence solutions; drive COA-related RWE strategy to differentiate assets, de-risk trials, and support value demonstration; advance conceptual modeling and dossier authoring using digital capabilities.
Clinical Development, Regulatory and Payer Excellence: Develop and implement next-generation capabilities to advance COA value and evidence generation; embed patient-driven outcomes strategies in trial design aligned with regulatory and HTA expectations; integrate digital COA solutions into trials for ease of implementation and participant experience; develop evidence packages including COAs, digital endpoints, and RWE for regulatory and payer submissions; collaborate with Regulatory Affairs to engage authorities on qualification of digital measures; collaborate with Market Access to link outcomes to value assessments across key markets.
External Engagement: Represent Sanofi in global consortia, regulatory workshops, and scientific forums focused on digital health and patient-centered outcomes; build strategic partnerships with technology providers, academic institutions, and patient advocacy organizations; drive thought leadership in patient-driven outcomes and evolve integrated patient engagement across the company.
Qualifications
Education: Advanced degree in health economics, qualitative and quantitative COA research, or related field.
Experience: 15+ years in the pharmaceutical, biotech, or healthcare industry; 10+ years in a senior leadership role focused on patient-driven outcomes, digital health, and real-world evidence integration; significant experience in digital innovation related to COA and successful value-creating initiatives; proven track record of submissions incorporating patient-centered outcomes; recognized thought leadership in the domain.
Skills: Deep understanding of clinical development, regulatory science, clinical outcomes, and health economics; expertise in digital health technologies and AI/ML applications; strong leadership, communication, and cross-functional collaboration; experience in a global, matrixed environment.
Education
Advanced degree in a relevant discipline related to health economics, qualitative and quantitative COA research.
Additional Requirements
N/A
#J-18808-Ljbffr